Market revenue in 2023 | USD 16.9 million |
Market revenue in 2030 | USD 23.6 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cell Perfusion System |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 43.79% in 2023. Horizon Databook has segmented the Norway perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Norway has one of the highest per capita GDPs globally. As a result, the country’s per capita health expenditure is significantly higher than most countries, with over USD 9,020.63 per capita in 2021. Moreover, public resources play a significant role, accounting for 85.5% of the current health expenditure, making it the highest share among EU countries.
In addition, the country’s rapidly aging population and the rising prevalence of chronic diseases significantly contribute to the demand for advanced medical technology, including perfusion systems. The perfusion system market in Norway is supported by a sophisticated, patient-centered healthcare system that prioritizes innovation, quality, & safety.
This infrastructure ensures that patients suffering from heart-related conditions receive excellent care and access the innovative perfusion system technologies & therapeutic alternatives. These developments give medical professionals access to the newest, most efficient methods for shortening patients’ recovery times.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway perfusion systems market , including forecasts for subscribers. This country databook contains high-level insights into Norway perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account